China National Medicines Corporation Ltd. (SHA: 600511)

China National Medicines Corporation Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25,970	21,594	21,051	23,789	37,205	20,590
Market Cap Growth	4.22%	2.58%	-11.51%	-36.06%	80.69%	15.86%
Enterprise Value	20,185	15,889	16,871	19,902	34,465	18,006
Last Close Price	34.42	27.89	26.63	29.35	45.15	24.59
PE Ratio	12.00	9.81	10.23	12.62	24.64	11.68
Forward PE	10.77	8.91	10.01	12.87	19.84	11.60
PS Ratio	0.51	0.43	0.46	0.51	0.92	0.46
PB Ratio	1.56	1.23	1.33	1.66	2.84	1.69
P/TBV Ratio	1.61	1.41	1.53	1.93	3.39	2.04
P/FCF Ratio	16.87	8.36	9.29	12.77	30.18	12.18
P/OCF Ratio	15.45	7.92	8.79	12.15	28.58	11.59
PEG Ratio	1.03	1.03	1.03	1.03	1.03	1.03
EV/Sales Ratio	0.39	0.32	0.37	0.43	0.85	0.40
EV/EBITDA Ratio	8.09	6.41	6.96	9.24	20.65	7.61
EV/EBIT Ratio	8.77	6.69	7.28	9.69	22.01	7.94
EV/FCF Ratio	13.11	6.15	7.45	10.69	27.96	10.65
Debt / Equity Ratio	0.04	0.03	0.03	0.05	0.06	0.05
Debt / EBITDA Ratio	0.27	0.21	0.21	0.31	0.46	0.23
Debt / FCF Ratio	0.43	0.21	0.23	0.38	0.65	0.33
Asset Turnover	1.55	1.60	1.58	1.76	1.64	1.95
Inventory Turnover	9.91	11.90	11.53	13.05	11.63	12.16
Quick Ratio	1.66	1.73	1.71	1.63	1.68	1.55
Current Ratio	2.04	2.04	2.02	1.93	1.97	1.87
Return on Equity (ROE)	13.20%	13.98%	14.09%	14.05%	11.95%	16.52%
Return on Assets (ROA)	4.36%	4.78%	5.03%	4.85%	3.99%	6.21%
Return on Capital (ROIC)	7.91%	8.61%	9.22%	8.87%	7.35%	11.65%
Earnings Yield	8.34%	9.94%	9.33%	7.37%	3.72%	7.79%
FCF Yield	5.93%	11.95%	10.76%	7.83%	3.31%	8.21%
Dividend Yield	2.43%	3.06%	2.94%	2.39%	1.22%	2.59%
Payout Ratio	34.70%	33.07%	31.16%	36.36%	44.34%	28.55%
Buyback Yield / Dilution	-0.00%	0.00%	0.00%	-0.00%	0.98%	0.62%
Total Shareholder Return	2.43%	3.06%	2.94%	2.38%	2.20%	3.22%

Source: S&P Capital IQ. Standard template. Financial Sources.